The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
AZoRobotics on MSN7d
AI Model Advances Parkinson’s ResearchAdvanced AI genetics models reveal key genetic markers and potential drug repurposing for Parkinson's disease, accelerating the search for new treatments.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback